Results
1 -
9 of
9Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and suceptibility to a mitochondrial toxin, Molecular and Cellular Biochemistry Therapeutic approaches to allergic and inflammatory diseases: Fourth annual midwest meeting of the Inflammation Research Association, Inflammation Research PDE inhibitors: early promise in asthma not yet converted to clinical success, Drugs & Therapy Perspectives Novel PDE IV inhibitors: exploring their potential in asthma, Inpharma Weekly